Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-107818
Filing Date
2024-10-10
Accepted
2024-10-10 21:05:33
Documents
2
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425730-10_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2425730-10_3seq1.xml 3 8739
2 EXHIBIT 24 tm2425730d10_ex24.htm EX-24 7272
  Complete submission text file 0001104659-24-107818.txt   17492
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Nashat Amir (Reporting) CIK: 0001575843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42365 | Film No.: 241366177

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)